Core Insights - The company reported an expected revenue of 905 million yuan for 2025, a slight decrease of 0.13% year-on-year, while net profit attributable to shareholders is projected to be 86.07 million yuan, reflecting a significant increase of 88.76% [1] Group 1: Revenue and Profit Performance - The expected revenue for 2025 is 905 million yuan, showing a year-on-year decline of 0.13% [1] - The net profit attributable to shareholders is expected to reach 86.07 million yuan, marking an impressive year-on-year growth of 88.76% [1] Group 2: Factors Contributing to Performance - The main reason for the performance growth is the commencement of operations at the largest egg product processing base in Southwest China, Sichuan Oufu, which has enabled the company to establish a comprehensive industrial layout across four major economic regions in China [1] - The company has effectively controlled supply chain logistics costs, enhancing its multi-faceted supply delivery capabilities and achieving synergistic effects [1] Group 3: Customer and Market Strategies - The company maintains a strong B-end customer base by providing comprehensive solutions, which has helped to retain and enhance customer loyalty [1] - The decline in raw egg prices has further improved the product gross margin [1] - The company is expanding its C-end business, launching new retail products such as ready-to-drink protein beverages and small-packaged egg liquids, which have gained consumer recognition and experienced significant growth [1] Group 4: International Expansion and New Projects - The company is actively seizing opportunities to expand into overseas markets, resulting in a substantial increase in foreign income [1] - The successful launch of the lysozyme project has led to exports that precisely match customer needs, creating new profit avenues for the company [1]

Investment Rating - The investment rating for the company is "Outperform" (Maintain) [2] Core Views - The company is positioned as a high-elasticity player in the egg cycle, with growth driven by international expansion and lysozyme projects [2] - The company anticipates a significant increase in net profit for 2025, projecting a range of 80 million to 92 million yuan, representing a year-on-year growth of 75.44% to 101.75% [2] - The report highlights the successful launch of the Sichuan Oufu processing base, which enhances the company's supply chain capabilities and product gross margins due to declining raw egg prices [3] - The international egg price surge in 2025 presents an opportunity for the company to expand its overseas market presence, with successful exports of its lysozyme project contributing to new profit growth [4] Financial Summary - The company expects revenue to grow from 906 million yuan in 2024 to 1.131 billion yuan in 2025, reflecting a year-on-year increase of 24.8% [6] - The projected net profit for 2025 is 84 million yuan, up from 46 million yuan in 2024, indicating an 84.3% year-on-year growth [6] - Gross margin is expected to improve from 16.6% in 2024 to 18.2% in 2025, while net margin is projected to rise from 5.0% to 7.4% [6][9] - The company's earnings per share (EPS) is forecasted to increase from 0.22 yuan in 2024 to 0.41 yuan in 2025, with a corresponding price-to-earnings (P/E) ratio decreasing from 49.3 to 26.7 [6]